{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T22:18:04Z","timestamp":1781734684162,"version":"3.54.5"},"reference-count":13,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2005,3,1]],"date-time":"2005-03-01T00:00:00Z","timestamp":1109635200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,3,1]],"date-time":"2005-03-01T00:00:00Z","timestamp":1109635200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2005,3]]},"DOI":"10.4158\/ep.11.2.135","type":"journal-article","created":{"date-parts":[[2013,4,5]],"date-time":"2013-04-05T21:32:59Z","timestamp":1365197579000},"page":"135-139","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Life-Threatening Thyrotoxicosis Induced by Combination Therapy with Peg-Interferon and Ribavirin in Chronic Hepatitis C"],"prefix":"10.1016","volume":"11","author":[{"given":"Yong Q.","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangbing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meena S.","family":"Murthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumon","family":"Agarwala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.4158\/EP.11.2.135_bb0005","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1002\/hep.510290529","article-title":"Prospective study of interferon therapy for compensated cirrhotic patients with chronic hepatitis C by monitoring serum hepatitis C RNA","volume":"29","author":"Shiratori","year":"1999","journal-title":"Hepatology"},{"key":"10.4158\/EP.11.2.135_bb0010","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1056\/NEJM199701303360507","article-title":"The treatment of chronic viral hepatitis","volume":"336","author":"Hoofnagle","year":"1997","journal-title":"N Engl J Med."},{"key":"10.4158\/EP.11.2.135_bb0015","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/hep.510260127","article-title":"Thyroid abnormalities in chronic viral hepatitis and their relationship to interferon alfa therapy","volume":"26","author":"Deutsch","year":"1997","journal-title":"Hepatology."},{"key":"10.4158\/EP.11.2.135_bb0020","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0168-8278(96)80113-9","article-title":"Side effects of high-dose interferon therapy for chronic hepatitis C","volume":"25","author":"Okanoue","year":"1996","journal-title":"J Hepatol."},{"key":"10.4158\/EP.11.2.135_bb0025","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1046\/j.1365-2265.2002.01553.x","article-title":"Thyrotoxicosis induced by alpha-interferon therapy in chronic viral hepatitis","volume":"56","author":"Wong","year":"2002","journal-title":"Clin Endocrinol."},{"key":"10.4158\/EP.11.2.135_bb0030","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1056\/NEJM199811193392101","article-title":"(Hepatitis Interventional Therapy Group). Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C","volume":"339","author":"McHutchison","year":"1998","journal-title":"N Engl J Med."},{"key":"10.4158\/EP.11.2.135_bb0035","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1530\/eje.0.1460743","article-title":"The addition of ribavirin to interferon-alpha therapy in patients with hepatitis C virus-related chronic hepatitis does not modify the thyroid autoantibody pattern but increases the risk of developing hypothyroidism","volume":"146","author":"Carella","year":"2002","journal-title":"Eur J Endocrinol."},{"key":"10.4158\/EP.11.2.135_bb0040","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1007\/BF03345087","article-title":"Temporal relationship between the appearance of thyroid autoantibodies and development of destructive thyroiditis in patients undergoing treatment with two different type-1 interferons for HCV-related chronic hepatitis: a prospective study","volume":"25","author":"Mazziotti","year":"2002","journal-title":"J Endocrinol Invest."},{"key":"10.4158\/EP.11.2.135_bb0045","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1046\/j.1365-2796.2002.00974.x","article-title":"Thyroid dysfunction during treatment of chronic hepatitis C with interferon alpha: no association with either interferon dosage or efficacy of therapy","volume":"251","author":"Dalgard","year":"2002","journal-title":"J Intern Med."},{"key":"10.4158\/EP.11.2.135_bb0050","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0025-7125(16)30090-6","article-title":"Thyroid storm","volume":"79","author":"Tietgens","year":"1995","journal-title":"Med Clin North Am."},{"key":"10.4158\/EP.11.2.135_bb0055","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0889-8529(18)30165-8","article-title":"Life-threatening thyrotoxicosis: thyroid storm","volume":"22","author":"Burch","year":"1993","journal-title":"Endocrinol Metab Clin North Am."},{"key":"10.4158\/EP.11.2.135_bb0060","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1210\/endo-45-5-504","article-title":"The temporary nature of the inhibitory action of excess iodine on organic iodine synthesis in the normal thyroid","volume":"45","author":"Wolff","year":"1949","journal-title":"Endocrinology"},{"key":"10.4158\/EP.11.2.135_bb0065","doi-asserted-by":"crossref","first-page":"3404","DOI":"10.1210\/endo.140.8.6893","article-title":"Escape from the acute Wolff-Chaikoff effect is associated with a decrease in thyroid sodium\/iodide symporter messenger ribonucleic acid and protein","volume":"140","author":"Eng","year":"1999","journal-title":"Endocrinology"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20399055?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20399055?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/aace.metapress.com\/index\/H07WMWW4F9H7GF5V.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:45:37Z","timestamp":1761515137000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X20399055"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,3]]},"references-count":13,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,3]]}},"alternative-id":["S1530891X20399055"],"URL":"https:\/\/doi.org\/10.4158\/ep.11.2.135","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2005,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Life-Threatening Thyrotoxicosis Induced by Combination Therapy with Peg-Interferon and Ribavirin in Chronic Hepatitis C","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/EP.11.2.135","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}